Cargando…
Asthma
Asthma is the most common respiratory disorder in Canada. Despite significant improvement in the diagnosis and management of this disorder, the majority of Canadians with asthma remain poorly controlled. In most patients, however, control can be achieved through the use of avoidance measures and app...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245435/ https://www.ncbi.nlm.nih.gov/pubmed/22165976 http://dx.doi.org/10.1186/1710-1492-7-S1-S2 |
_version_ | 1782219858423840768 |
---|---|
author | Kim, Harold Mazza, Jorge |
author_facet | Kim, Harold Mazza, Jorge |
author_sort | Kim, Harold |
collection | PubMed |
description | Asthma is the most common respiratory disorder in Canada. Despite significant improvement in the diagnosis and management of this disorder, the majority of Canadians with asthma remain poorly controlled. In most patients, however, control can be achieved through the use of avoidance measures and appropriate pharmacological interventions. Inhaled corticosteroids (ICSs) represent the standard of care for the majority of patients. Combination ICS/long-acting beta(2)-agonists (LABA) inhalers are preferred for most adults who fail to achieve control with ICS therapy. Allergen-specific immunotherapy represents a potentially disease-modifying therapy for many patients with asthma, but should only be prescribed by physicians with appropriate training in allergy. Regular monitoring of asthma control, adherence to therapy and inhaler technique are also essential components of asthma management. This article provides a review of current literature and guidelines for the appropriate diagnosis and management of asthma. |
format | Online Article Text |
id | pubmed-3245435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32454352011-12-24 Asthma Kim, Harold Mazza, Jorge Allergy Asthma Clin Immunol Review Asthma is the most common respiratory disorder in Canada. Despite significant improvement in the diagnosis and management of this disorder, the majority of Canadians with asthma remain poorly controlled. In most patients, however, control can be achieved through the use of avoidance measures and appropriate pharmacological interventions. Inhaled corticosteroids (ICSs) represent the standard of care for the majority of patients. Combination ICS/long-acting beta(2)-agonists (LABA) inhalers are preferred for most adults who fail to achieve control with ICS therapy. Allergen-specific immunotherapy represents a potentially disease-modifying therapy for many patients with asthma, but should only be prescribed by physicians with appropriate training in allergy. Regular monitoring of asthma control, adherence to therapy and inhaler technique are also essential components of asthma management. This article provides a review of current literature and guidelines for the appropriate diagnosis and management of asthma. BioMed Central 2011-11-10 /pmc/articles/PMC3245435/ /pubmed/22165976 http://dx.doi.org/10.1186/1710-1492-7-S1-S2 Text en Copyright ©2011 Kim and Mazza; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Kim, Harold Mazza, Jorge Asthma |
title | Asthma |
title_full | Asthma |
title_fullStr | Asthma |
title_full_unstemmed | Asthma |
title_short | Asthma |
title_sort | asthma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245435/ https://www.ncbi.nlm.nih.gov/pubmed/22165976 http://dx.doi.org/10.1186/1710-1492-7-S1-S2 |
work_keys_str_mv | AT kimharold asthma AT mazzajorge asthma |